Skip to content

AngioDynamics ANGO Total other income (expense), net

Total other income (expense), net at other companies

KRAKacquisition
 logo
KRAKacquisition KRAQ
$2.05M
Hubbell logo
HubbellHUBB
-$27.4M-43.5%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$409.8K-37.8%
PBH
Prestige Consumer HealthcarePBH
-$10.72M+25.9%
HTF
Heartflow, Inc. Common StockHTFL
$2.15M+114%
Cal-Maine Foods logo
Cal-Maine FoodsCALM
$22.24M-18.7%

Other financials

Income statement

See full
Revenue$78.4M+8.9%
Gross profit$41.5M+6.7%
Operating income-$13.0M-29.8%
Net income-$8.1M-83.4%
EPS (diluted)-$0.19-72.7%

Balance sheet

See full
Cash & equivalents$37.8M-15.5%
Total debt$7.9M+10.2%
Total equity$173.4M-6.7%
Total assets$260.7M-8.7%

Cash flow

See full
Operating cash flow-$3.1M+76.4%
CapEx$1.0M-43.5%
Free cash flow-$4.1M+72.4%

Valuation

See full
Market cap$564.42M+38.7%
Enterprise value$534.51M+48.0%
P/S1.8×+0.4×

Profitability

See full
Gross margin54.3%-0.1pp
Operating margin-11.3%-2.9pp
Net margin-10%-2.4pp
FCF margin5.5%

Returns & leverage

See full
Return on equity-17.5%-2.2pp
Debt / equity0.0×
Current ratio2.4×+0.1×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept ango:OtherNonoperatingIncomeExpenseAndInterestExpense.

The official record: AngioDynamics’s 10-K, filed July 18, 2025, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's total other income (expense), net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AngioDynamics's total other income (expense), net?
AngioDynamics (ANGO) reported total other income (expense), net of $1.48M in Q1 2025.
How has AngioDynamics's total other income (expense), net changed year-over-year?
AngioDynamics's total other income (expense), net increased by 643.0% year-over-year, from $199.25K to $1.48M.
What is the long-term trend for AngioDynamics's total other income (expense), net?
Over 4 years (2021 to 2025), AngioDynamics's total other income (expense), net has grown at a 66.6% compound annual growth rate (CAGR), from -$769K to $5.92M.
What does total other income (expense), net mean?
This metric captures the net impact of financial activities that fall outside of the company's primary business operations, including interest income, interest expense, and gains or losses from non-core asset sales or currency fluctuations. It provides a comprehensive view of the company's capital structure costs and peripheral financial performance. Analyzing this helps investors understand the impact of financing decisions and non-operating events on the bottom line.